- Coronary Intervention
- Peripheral Intervention
- Vessel Closure
- Carotid Intervention
- Humanitarian Use Device
POWERSAIL Coronary Dilatation Catheter
Indications & Important Safety Information ›› IFU (Full Version) ››
Powerful Balance: High Pressure, High Performance*
The POWERSAIL (RX) and HIGHSAIL (OTW) Coronary Dilatation Catheters are high pressure, non-compliant catheters. The POWERSAIL and HIGHSAIL incorporate several engineering technologies over the previous high-pressure generation devices for exceptionally deliverable non-compliant balloons.
PLATEAU Balloon Material provides non-compliance at high pressure, yet PLATEAU is flexible and conformable without compromising deliverability. The combination of PLATEU, LOFOLD Balloon Technology and the flexible, tapered Soft Tip design contribute to a low crossing profile for exceptional lesion cross and recross.
Short balloon tapers facilitate precise, focalized lesion treatment.
The POWERSAIL includes a tapered FLEXIPUSH Support Wire shaft technology designed to improved push and minimize junction kinking.
The HIGHSAIL ELASTICORE shaft technology for excellent push efficiency.
*Tests performed by and data on file at Abbott Vascular
![]() see larger view |
PLATEAU Balloon Material*
|
![]() see larger view |
LOFOLD Balloon Technology*
|
![]() see larger view |
Soft Tip Design*
|
![]() see larger view |
Dual Swaged Markers*
|
![]() see larger view |
FLEXIPUSH Support Wire (POWERSAIL RX)*
|
![]() see larger view |
ELASTICORE Technology (HIGHSAIL OTW)*
|
*Tests performed by and data on file at Abbott Vascular

AP2932825 Rev.A
Indications and Important Safety Information
Powersail Coronary Dilatation Catheter
INDICATIONS
The POWERSAIL Coronary Dilatation Catheter is indicated for:
a) balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis for the purpose of improving myocardial perfusion.
b) balloon dilatation of a coronary artery occlusion for the purpose of restoring coronary flow in patients with ST-segment elevation myocardial infarction.
c) balloon dilatation of the Guidant MULTI-LINK Stent, MULTI-LINK DUET Stent, MULTI-LINK TRISTAR Stent, MULTI-LINK TETRA Stent or MULTI-LINK ULTRA Stent after implantation. This indication applies to the following balloon sizes and stent lengths:
| Balloon Size | Stent Length | |
| 2.5 – 4.0 mm x 8 mm | 8 mm |
|
| 2.5 – 5.0 mm x 13 mm | 13 mm | |
| 2.5 – 4.0 mm x 15 mm | 15 mm | |
| 2.5 – 4.0 mm x 23 mm | 18 mm | |
| 2.5 – 4.0 mm x 23 mm | 23 mm | |
| 2.5 – 5.0 mm x 28 mm | 28 mm | |
| 3.0 – 4.0 mm x 33 mm | 33 mm | |
| 3.0 – 3.5 mm x 33 mm | 35 mm | |
| 3.0 – 4.0 mm x 33 mm | 38 mm |
CONTRAINDICATIONS
The POWERSAIL Coronary Dilatation Catheter is not intended to be used:
- in an unprotected left main coronary artery.
- to treat coronary artery spasm in the absence of a significant stenosis.
WARNINGS AND PRECAUTIONS
WARNINGS
This device is intended for one time use only. DO NOT resterilize and/or reuse it, as this can compromise device performance and increase the risk of cross contamination due to inappropriate
reprocessing.
PTCA should only be performed at hospitals where emergency coronary artery bypass graft surgery can be quickly performed in the event of a potentially injurious or life-threatening complication.
PTCA in patients who are not acceptable candidates for coronary artery bypass graft surgery requires careful consideration, including possible hemodynamic support during PTCA, as treatment of this patient population carries special risk.
Use only the recommended balloon inflation medium. Never use air or any gaseous medium to inflate the balloon.
Balloon pressure should not exceed the rated burst pressure (RBP). The RBP is based on results of in vitro testing. At least 99.9% of the balloons (with a 95% confidence) will not burst at or below their RBP. Use of a pressure-monitoring device is recommended to prevent over pressurization.
To reduce the potential for vessel damage, the inflated diameter of the balloon should approximate the diameter of the vessel just proximal and distal to the stenosis.
Use the catheter prior to the "Use By" date specified on the package.
When the catheter is exposed to the vascular system, it should be manipulated while under high quality fluoroscopic observation. Do not advance or retract the catheter unless the balloon is fully deflated under vacuum and no resistance is felt. If there is resistance, determine the cause before proceeding. Continuing to advance or retract the catheter while under resistance may result in damage to the vessels and/or damage/separation of the catheter.
Never apply extreme bending or twisting force to any section of the catheter in order to prevent kinking or damage/separation of the shaft.
Treatment of moderately or heavily calcified lesions is considered to be moderate risk, with an expected success rate of 60-85% and increases the risk of acute closure, vessel trauma, balloon burst, balloon entrapment and associated complications. If resistance is felt, determine the cause before proceeding. Continuing to advance or retract the catheter while under resistance may result in damage to the vessels and/or damage/separation of the catheter.
In the event of catheter damage/separation, recovery of any portion should be performed based on physician determination of individual patient condition and appropriate retrieval protocol.
PRECAUTIONS
This device should be used only by physicians trained in angiography and percutaneous transluminal coronary angioplasty (PTCA), and/or percutaneous transluminal angioplasty (PTA).
Prior to angioplasty, the dilatation catheter should be examined to verify functionality and ensure that its size is suitable for the specific procedure for which it is to be used.
During the procedure, appropriate anticoagulant and coronary vasodilator therapy must be provided to the patient as needed. Anticoagulant therapy should be continued for a period of time to be determined by the physician after the procedure.
The design and construction of these catheters do not provide the user with distal pressure monitoring capability.
If the surface of the POWERSAIL Coronary Dilatation Catheter becomes dry, wetting with heparinized normal saline will reactivate the coating.
Do not reinsert the POWERSAIL Coronary Dilatation Catheter into the coil dispenser after procedural use.
With 4.5 mm and 5.0 mm balloon dilatation catheters, some increased resistance may be noted upon insertion or withdrawal into or out of the guiding catheter. Choosing a larger guiding catheter size may minimize this.
ADVERSE EVENTS
Possible adverse events include, but are not limited to, the following:
• acute myocardial infarction • arrhythmias, including ventricular fibrillation
• arteriovenous fistula • coronary artery spasm • coronary vessel dissection, perforation, rupture or injury • death • drug reactions, allergic reaction to contrast medium • embolism • hemorrhage or hematoma • hypo/hypertension • infection
• restenosis of the dilated vessel • total occlusion of the coronary artery or bypass graft • unstable angina








